Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population

Wen Fu1, Zhen-Jian Zhuo2, Wei Jia1

  • 1Department of Pediatric Urology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong; Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong.

Insights

The TP53 gene Arg72Pro polymorphism shows no overall association with Wilms' tumor risk in Chinese children. However, it may increase risk in younger children, suggesting an age-related effect.

Area of Science:

  • Genetics
  • Oncology
  • Pediatrics

Background:

  • Wilms' tumor is a common pediatric cancer.
  • TP53 gene mutations are linked to cancer development.
  • TP53 Arg72Pro polymorphism is a potential cancer risk factor.

Purpose of the Study:

  • To investigate the association between TP53 Arg72Pro polymorphism and Wilms' tumor risk in Chinese children.
  • To explore potential age-related effects of this polymorphism on Wilms' tumor susceptibility.

Main Methods:

  • Genotyping of the TP53 Arg72Pro polymorphism (rs1042522 C>G) using Taqman methodology.
  • Case-control study involving 145 Wilms' tumor patients and 531 cancer-free controls.
  • Stratified analysis based on age at diagnosis.

Main Results:

  • No significant overall association was found between TP53 Arg72Pro polymorphism and Wilms' tumor risk.
  • A statistically significant increased risk of Wilms' tumor was observed in children aged 18 months or younger carrying CG/GG genotypes (OR=2.04, P=0.049).

Conclusions:

  • The TP53 Arg72Pro polymorphism may not be a major risk factor for Wilms' tumor in general.
  • An age-dependent association suggests a potential role in early-onset Wilms' tumor.
  • Further validation in larger, diverse populations is warranted.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K